At the first level, exposure of murine splenocytes and BMC to apoptotic signals without host-specific priming results in balanced reduction in CD4+ and CD8+ T cells, each one having the capacity to mediate experimental and clinical GvHD (41–43). Here, CD8A is linked to graft versus host disease.